Vanguard Group »

Design Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 997k 2.65
2023-09-30 $2.3M 987k 2.36
2023-06-30 $6.2M 983k 6.30
2023-03-31 $7.4M 1.3M 5.77
2022-12-31 $16M 1.6M 10.26
2022-06-30 $18M 1.3M 14.00
2022-03-31 $30M 1.9M 16.15
2021-09-30 $16M 1.1M 14.69
2021-06-30 $24M 1.2M 19.87
2021-03-31 $3.7M 125k 30.00